Menopur Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

75 IU: The most frequently reported adverse drug reactions (ADR) during treatment with MENOPUR in clinical trials are Ovarian Hyperstimulation Syndrome (OHSS), headache, pelvic pain, pelvic discomfort, abdominal pain, abdominal distension, nausea and injection site reactions.
600 IU and 1200 IU: The most frequently reported adverse drug reactions (ADR) during treatment with MENOPUR in clinical trials are Ovarian Hyperstimulation Syndrome, OHSS, headache, abdominal pain, abdominal distension and injection site pain.
None of these ADRs have been reported with an incidence rate of more than 5%.
The table as follows displays the main ADRs in women treated with MENOPUR in clinical trials distributed by system organ classes (SOCs) and frequency. Further, the ADRs seen during post-marketing experience are mentioned with unknown frequency.
75 IU: (See Table 1.)

Click on icon to see table/diagram/image

600 IU and 1200 IU: (See Table 2.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Manufacturer:

Ferring

Distributor:

Zuellig Pharma